secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jazz Pharmaceuticals plc (JAZZ)
CIK:        0001232524
Form:       8-K/A
Filed at:   2025-03-05T23:59:59+00:00
Accession:  0001193125-25-047189
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Jazz Pharmaceuticals to acquire Chimerix for $8.55/share in all-cash tender offer
--------------------------------------------------------------------------------

- Tender offer to commence by March 24, 2025; Chimerix board unanimously recommends.
- Offer subject to minimum tender condition, HSR clearance, and no material adverse effect.
- After tender, merger under DGCL Section 251(h); remaining shares converted at same $8.55.
- Amendment No. 1 corrects typographical error in exhibit; no substantive changes to terms.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1232524/000119312525047189/0001193125-25-047189-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1232524/000119312525047189/d844531d8ka.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-047189

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer